Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01844934 · ClinicalTrials.gov registry record · NA

Impact of Prehabilitation in Total Knee Replacement

A NA study of Total Knee Arthroplasty, sponsored by Allina Health System.

Completed
Registry status
NA
Development phase
43
Enrollment target
1
Study location

NCT01844934: Completed NA study of Total Knee Arthroplasty, sponsored by Allina Health System.

NCT01844934 is a NA study of Total Knee Arthroplasty that has completed, run by Allina Health System. The registered enrollment target is 43 participants, below the 293-participant average among 29 other Total Knee Arthroplasty trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01844934, a NA study of Total Knee Arthroplasty, has completed, sponsored by Allina Health System.

COMPLETED
Registry status
NA
Development phase
43 participants
Enrollment target
1
Study location

Study Summary

A study comparing the benefits of pre-habilitation exercise to standard care prior to total knee arthroplasy

Primary Outcome

WOMAC, a self-assessment tool, is a valid and reliable instrument developed specifically to measure outcomes related to interventions for treatment of the hip and knee. Consisting of three domains: physical, pain and stiffness; a total score is derived by aggregating the domain scores.

Conditions Studied

Interventions

  • OTHER Prehabilitation

Study Locations (1)

Minnesota

  • Unity Hospital - Fridley

Trial Details

FieldValue
Enrollment Target 43 participants
Start Date 2014-01-01
Est. Completion 2016-12-01
Phase NA
Allina Health System

32 total trials

What the finished NCT01844934 record still lists

NCT01844934 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 43 participants, a relatively small participant target, below the 293-participant average among 29 other Total Knee Arthroplasty trials with a reported enrollment target (85% lower).

The record links to 1 condition, with Total Knee Arthroplasty appearing as the primary indexed condition, and to 1 intervention - of which Prehabilitation is the first listed.

NCT01844934 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT01844934 about?

NCT01844934 is a clinical study titled "Impact of Prehabilitation in Total Knee Replacement". A study comparing the benefits of pre-habilitation exercise to standard care prior to total knee arthroplasy

What is the current status of trial NCT01844934?

This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2014-01-01. Estimated completion is 2016-12-01.

What conditions does trial NCT01844934 study?

This clinical trial studies the following conditions: Total Knee Arthroplasty.

What interventions are being tested in trial NCT01844934?

The interventions under investigation include: Prehabilitation (OTHER).

Who is sponsoring clinical trial NCT01844934?

This trial is sponsored by Allina Health System, which has 32 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01844934 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Total Knee Arthroplasty

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01844934's enrollment target sits among peer trials

43 27th of 29 higher than 3 of 29 other Total Knee Arthroplasty trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Total Knee Arthroplasty trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03726359 · 43 participants · Phase 1

    Phase I Study of Fractionated Stereotactic Radiation Therapy

  • NCT03850418 · 43 participants · Phase 2

    Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant

  • NCT04144023 · 43 participants · Phase 1

    A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ

  • NCT04176718 · 43 participants · Phase 2

    Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01844934, the US trial registry maintained by the National Library of Medicine. NCT01844934 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.